KBC Group NV Decreases Position in Cardinal Health, Inc. (NYSE:CAH)

KBC Group NV lowered its position in Cardinal Health, Inc. (NYSE:CAH) by 1.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 810,427 shares of the company’s stock after selling 10,635 shares during the quarter. KBC Group NV owned 0.33% of Cardinal Health worth $95,849,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in CAH. Paragon Capital Management Inc. raised its position in Cardinal Health by 0.7% during the second quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company’s stock worth $1,451,000 after acquiring an additional 99 shares during the last quarter. Huntington National Bank increased its stake in shares of Cardinal Health by 0.9% during the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company’s stock worth $1,193,000 after purchasing an additional 100 shares in the last quarter. Frazier Financial Advisors LLC raised its position in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares during the last quarter. UMB Bank n.a. lifted its stake in Cardinal Health by 4.9% in the 3rd quarter. UMB Bank n.a. now owns 2,249 shares of the company’s stock valued at $249,000 after buying an additional 106 shares in the last quarter. Finally, Raleigh Capital Management Inc. grew its holdings in Cardinal Health by 29.6% during the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock valued at $55,000 after buying an additional 106 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.3 %

CAH stock opened at $128.89 on Monday. The company has a market cap of $31.19 billion, a PE ratio of 25.08, a price-to-earnings-growth ratio of 1.57 and a beta of 0.63. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $129.68. The stock has a 50-day moving average price of $121.36 and a two-hundred day moving average price of $113.16.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. Cardinal Health’s revenue for the quarter was down 4.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.73 earnings per share. Equities analysts forecast that Cardinal Health, Inc. will post 7.82 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd were given a dividend of $0.5056 per share. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.57%. Cardinal Health’s dividend payout ratio (DPR) is 39.30%.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on CAH shares. UBS Group upped their price objective on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research report on Monday, November 4th. StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Bank of America raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $132.00 to $145.00 in a research report on Monday, January 6th. JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $132.00 to $142.00 and gave the stock a “neutral” rating in a research report on Friday. Finally, Barclays increased their price target on Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus price target of $134.64.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.